“We are in the final stages of negotiating contracts with very significant and large, global generic manufacturing companies, which provides another level of commercial validation for Phlow’s products,” revealed Eric Edwards, CEO of Phlow Corp, in the second part of an exclusive interview with Generics Bulletin.
Having in the first part of the interview emphasized the importance to the US of domestic manufacturing for key medicines...





